Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood

Trial ID or NCT#

NCT03638427

Status

recruiting iconRECRUITING

Purpose

The purpose of this study is to investigate the feasibility and efficacy of assessing HR-HPV DNA and HPV E6/E7 mRNA via self-collected menstrual blood in a smart menstrual pad. In other words, can the investigators detect the high risk strains of the human papilloma virus (HPV) that are associated with cervical cancer in self-collected menstrual blood, as an alternative to collecting vaginal swabs.

Official Title

Screening for Cervical Intraepithelial Neoplasia Using Self-collected Menstrual Blood

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: Female
Accepts Healthy Volunteers: Yes
Inclusion Criteria:
  1. There will be two study groups: 1) menstruating women over the age of 18 who have previous history of HR-HPV in the last 18 months and 2) menstruating women over the age of 18 who do not have a previous history of HR-HPV.
Exclusion Criteria:
  1. - Women younger than 18 years old or are not menstruating regularly
View All Criteria
Show Less

Investigator(s)

Paul D. Blumenthal, MD, MPH
Paul D. Blumenthal, MD, MPH
Obstetrician and Gynecologist (OB-GYN), Family planning specialist
Professor of Obstetrics and Gynecology (Gynecology-Family Planning) at the Stanford University Medical Center, Emeritus

Contact us to find out if this trial is right for you.

Contact

Klaira M Lerma, MPH
16507211562

SEND MESSAGE

View on ClinicalTrials.gov